Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Colorectal Neoplasms

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 309 articles:
HTML format
Text format



Single Articles


    January 2020
  1. FRANCZAK C, Witz A, Geoffroy K, Demange J, et al
    Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer.
    PLoS One. 2020;15:e0227294.
    PubMed     Text format     Abstract available


  2. JANA A, Das A, Krett NL, Guzman G, et al
    Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer.
    PLoS One. 2020;15:e0227916.
    PubMed     Text format     Abstract available


  3. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer.
    PLoS One. 2020;15:e0228466.
    PubMed     Text format     Abstract available


  4. HOFMANOVA J, Slavik J, Ovesna P, Tylichova Z, et al
    Phospholipid profiling enables to discriminate tumor- and non-tumor-derived human colon epithelial cells: Phospholipidome similarities and differences in colon cancer cell lines and in patient-derived cell samples.
    PLoS One. 2020;15:e0228010.
    PubMed     Text format     Abstract available


  5. IYADORAI T, Mariappan V, Vellasamy KM, Wanyiri JW, et al
    Prevalence and association of pks+ Escherichia coli with colorectal cancer in patients at the University Malaya Medical Centre, Malaysia.
    PLoS One. 2020;15:e0228217.
    PubMed     Text format     Abstract available


  6. CHARTIER LC, Hebart ML, Howarth GS, Whittaker AL, et al
    Affective state determination in a mouse model of colitis-associated colorectal cancer.
    PLoS One. 2020;15:e0228413.
    PubMed     Text format     Abstract available


  7. POWELL W, Frerichs L, Townsley R, Mayorga M, et al
    The potential impact of the Affordable Care Act and Medicaid expansion on reducing colorectal cancer screening disparities in African American males.
    PLoS One. 2020;15:e0226942.
    PubMed     Text format     Abstract available


  8. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Text format     Abstract available


  9. KOPP TI, Vogel U, Andersen V
    Associations between common polymorphisms in CYP2R1 and GC, Vitamin D intake and risk of colorectal cancer in a prospective case-cohort study in Danes.
    PLoS One. 2020;15:e0228635.
    PubMed     Text format     Abstract available


  10. YAMAJI T, Iwasaki M, Sawada N, Shimazu T, et al
    Fat mass and obesity-associated gene polymorphisms, pre-diagnostic plasma adipokine levels and the risk of colorectal cancer: The Japan Public Health Center-based Prospective Study.
    PLoS One. 2020;15:e0229005.
    PubMed     Text format     Abstract available


  11. OLSSON L, Hammarstrom ML, Israelsson A, Lindmark G, et al
    Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.
    PLoS One. 2020;15:e0229007.
    PubMed     Text format     Abstract available


  12. LV Y, Duanmu J, Fu X, Li T, et al
    Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    PLoS One. 2020;15:e0228575.
    PubMed     Text format     Abstract available


  13. DARBA J, Marsa A
    Results after 10 years of colorectal cancer screenings in Spain: Hospital incidence and in-hospital mortality (2011-2016).
    PLoS One. 2020;15:e0228795.
    PubMed     Text format     Abstract available


  14. CLARKE SJ, Burge M, Feeney K, Gibbs P, et al
    The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
    PLoS One. 2020;15:e0229900.
    PubMed     Text format     Abstract available


  15. GHARIB E, Nasrinasrabadi P, Zali MR
    Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
    PLoS One. 2020;15:e0229864.
    PubMed     Text format     Abstract available


  16. FARHANA L, Sarkar S, Nangia-Makker P, Yu Y, et al
    Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice.
    PLoS One. 2020;15:e0229823.
    PubMed     Text format     Abstract available


    January 2019
  17. NEILSEN BK, Frodyma DE, McCall JL, Fisher KW, et al
    ERK-mediated TIMELESS expression suppresses G2/M arrest in colon cancer cells.
    PLoS One. 2019;14:e0209224.
    PubMed     Text format     Abstract available


  18. CHEN M, Xu R, Rai A, Suwakulsiri W, et al
    Distinct shed microvesicle and exosome microRNA signatures reveal diagnostic markers for colorectal cancer.
    PLoS One. 2019;14:e0210003.
    PubMed     Text format     Abstract available


  19. SARTOR ITS, Recamonde-Mendoza M, Ashton-Prolla P
    TULP3: A potential biomarker in colorectal cancer?
    PLoS One. 2019;14:e0210762.
    PubMed     Text format     Abstract available


  20. LEE YH, Kung PT, Wang YH, Kuo WY, et al
    Effect of length of time from diagnosis to treatment on colorectal cancer survival: A population-based study.
    PLoS One. 2019;14:e0210465.
    PubMed     Text format     Abstract available


  21. CHANG TC, Wei PL, Makondi PT, Chen WT, et al
    Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy.
    PLoS One. 2019;14:e0210274.
    PubMed     Text format     Abstract available


  22. RIOUX CR, Clapper ML, Cooper HS, Michaud J, et al
    Self-antigen MASH2 combined with the AS15 immunostimulant induces tumor protection in colorectal cancer mouse models.
    PLoS One. 2019;14:e0210261.
    PubMed     Text format     Abstract available


  23. NERAD E, Delli Pizzi A, Lambregts DMJ, Maas M, et al
    The Apparent Diffusion Coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor.
    PLoS One. 2019;14:e0211830.
    PubMed     Text format     Abstract available


  24. SHAHRIYARI L, Abdel-Rahman M, Cebulla C
    BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    PLoS One. 2019;14:e0211507.
    PubMed     Text format     Abstract available


  25. KAPRIO T, Rasila T, Hagstrom J, Mustonen H, et al
    Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.
    PLoS One. 2019;14:e0211564.
    PubMed     Text format     Abstract available


  26. KLOSE J, Trefz S, Wagner T, Steffen L, et al
    Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
    PLoS One. 2019;14:e0211916.
    PubMed     Text format     Abstract available


  27. YANG B, Pan CS, Li Q, Yang Z, et al
    Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice.
    PLoS One. 2019;14:e0201504.
    PubMed     Text format     Abstract available


  28. DOUMA LN, Uiters E, Timmermans DRM
    Do people with a different goal-orientation or specific focus make different decisions about colorectal cancer-screening participation?
    PLoS One. 2019;14:e0213003.
    PubMed     Text format     Abstract available


  29. TSUTSUYAMA M, Nakanishi H, Yoshimura M, Oshiro T, et al
    Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform.
    PLoS One. 2019;14:e0212221.
    PubMed     Text format     Abstract available


  30. MAKONDI PT, Wei PL, Huang CY, Chang YJ, et al
    Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.
    PLoS One. 2019;14:e0211968.
    PubMed     Text format     Abstract available


  31. ACKERMANN A, Schrecker C, Bon D, Friedrichs N, et al
    Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
    PLoS One. 2019;14:e0213411.
    PubMed     Text format     Abstract available


  32. YAMAGUCHI M, Okamura S, Yamaji T, Iwasaki M, et al
    Plasma cytokine levels and the presence of colorectal cancer.
    PLoS One. 2019;14:e0213602.
    PubMed     Text format     Abstract available


  33. STOFFEL ST, Yang J, Vlaev I, von Wagner C, et al
    Testing the decoy effect to increase interest in colorectal cancer screening.
    PLoS One. 2019;14:e0213668.
    PubMed     Text format     Abstract available


  34. KIM EJ, Woo HS, Cho JH, Sym SJ, et al
    Early experience with Watson for oncology in Korean patients with colorectal cancer.
    PLoS One. 2019;14:e0213640.
    PubMed     Text format     Abstract available


  35. FENG YY, Zeng DZ, Tong YN, Lu XX, et al
    Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
    PLoS One. 2019;14:e0215088.
    PubMed     Text format     Abstract available


  36. LI X, Zhong Q, Luo D, Du Q, et al
    The prognostic value of CXC subfamily ligands in stage I-III patients with colorectal cancer.
    PLoS One. 2019;14:e0214611.
    PubMed     Text format     Abstract available


  37. LIU Z, Duan ZJ, Chang JY, Zhang ZF, et al
    Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression.
    PLoS One. 2019;14:e0215388.
    PubMed     Text format    


  38. NAKAYAMA Y, Iijima T, Wakaume R, Takahashi K, et al
    Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer.
    PLoS One. 2019;14:e0215513.
    PubMed     Text format     Abstract available


  39. ARRIBA M, Sanchez C, Vivas A, Nutu OA, et al
    Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer.
    PLoS One. 2019;14:e0216472.
    PubMed     Text format     Abstract available


  40. K B A, Madhavan A, T R R, Thomas S, et al
    Short chain fatty acids enriched fermentation metabolites of soluble dietary fibre from Musa paradisiaca drives HT29 colon cancer cells to apoptosis.
    PLoS One. 2019;14:e0216604.
    PubMed     Text format     Abstract available


  41. LU S, Catalano C, Huhn S, Pardini B, et al
    Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    PLoS One. 2019;14:e0216666.
    PubMed     Text format     Abstract available


  42. LU S, Catalano C, Huhn S, Pardini B, et al
    Correction: Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    PLoS One. 2019;14:e0218064.
    PubMed     Text format     Abstract available


  43. LIN XH, Jiang JK, Luo JC, Lin CC, et al
    The long term microbiota and metabolic status in patients with colorectal cancer after curative colon surgery.
    PLoS One. 2019;14:e0218436.
    PubMed     Text format     Abstract available


  44. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.
    PLoS One. 2019;14:e0218207.
    PubMed     Text format     Abstract available


  45. VASHI PG, Gorsuch K, Wan L, Hill D, et al
    Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
    PLoS One. 2019;14:e0218761.
    PubMed     Text format     Abstract available


  46. CHEONG C, Oh SY, Kim YB, Suh KW, et al
    Differences in biological behaviors between young and elderly patients with colorectal cancer.
    PLoS One. 2019;14:e0218604.
    PubMed     Text format     Abstract available


  47. GILSON P, Franczak C, Dubouis L, Husson M, et al
    Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    PLoS One. 2019;14:e0219204.
    PubMed     Text format     Abstract available


  48. KARLSSON E, Farahnak P, Franzen E, Nygren-Bonnier M, et al
    Feasibility of preoperative supervised home-based exercise in older adults undergoing colorectal cancer surgery - A randomized controlled design.
    PLoS One. 2019;14:e0219158.
    PubMed     Text format     Abstract available


  49. STOFFEL ST, Yang J, Vlaev I, von Wagner C, et al
    Correction: Testing the decoy effect to increase interest in colorectal cancer screening.
    PLoS One. 2019;14:e0219811.
    PubMed     Text format     Abstract available


  50. MIZUNO H, Yuasa N, Takeuchi E, Miyake H, et al
    Blood cell markers that can predict the long-term outcomes of patients with colorectal cancer.
    PLoS One. 2019;14:e0220579.
    PubMed     Text format     Abstract available


  51. TAIBI A, Albouys J, Jacques J, Perrin ML, et al
    Comparison of implantation sites for the development of peritoneal metastasis in a colorectal cancer mouse model using non-invasive bioluminescence imaging.
    PLoS One. 2019;14:e0220360.
    PubMed     Text format     Abstract available


  52. ZHAO Y, Yi C, Zhang Y, Fang F, et al
    Intensive follow-up strategies after radical surgery for nonmetastatic colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0220533.
    PubMed     Text format     Abstract available


  53. LI W, Cho MY, Lee S, Jang M, et al
    CRISPR-Cas9 mediated CD133 knockout inhibits colon cancer invasion through reduced epithelial-mesenchymal transition.
    PLoS One. 2019;14:e0220860.
    PubMed     Text format     Abstract available


  54. GLAZKO G, Zybailov B, Emmert-Streib F, Baranova A, et al
    Proteome-transcriptome alignment of molecular portraits achieved by self-contained gene set analysis: Consensus colon cancer subtypes case study.
    PLoS One. 2019;14:e0221444.
    PubMed     Text format     Abstract available


  55. NARTOWT BJ, Hart GR, Roffman DA, Llor X, et al
    Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data.
    PLoS One. 2019;14:e0221421.
    PubMed     Text format     Abstract available


  56. CALLAHAN KE, Ponce CP, Cross CL, Sy FS, et al
    Low colorectal cancer survival in the Mountain West state of Nevada: A population-based analysis.
    PLoS One. 2019;14:e0221337.
    PubMed     Text format     Abstract available


  57. GMEREK L, Martyniak K, Horbacka K, Krokowicz P, et al
    MicroRNA regulation in colorectal cancer tissue and serum.
    PLoS One. 2019;14:e0222013.
    PubMed     Text format     Abstract available


  58. ALMUTAIRI M, Parine NR, Shaik JP, Aldhaian S, et al
    Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.
    PLoS One. 2019;14:e0220931.
    PubMed     Text format     Abstract available


  59. NABER SK, Knudsen AB, Zauber AG, Rutter CM, et al
    Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries.
    PLoS One. 2019;14:e0220234.
    PubMed     Text format     Abstract available



  60. Retraction: APRIL Induces Tumorigenesis and Metastasis of Colorectal Cancer Cells via Activation of the PI3K/Akt Pathway.
    PLoS One. 2019;14:e0222525.
    PubMed     Text format    


  61. CHEN N, Kong Y, Wu Y, Gao Q, et al
    CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer.
    PLoS One. 2019;14:e0222035.
    PubMed     Text format     Abstract available


  62. LU L, Zhuang T, Shao E, Liu Y, et al
    Association of antibiotic exposure with the mortality in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy: A hospital-based retrospective cohort study.
    PLoS One. 2019;14:e0221964.
    PubMed     Text format     Abstract available


  63. LATHWAL A, Arora C, Raghava GPS
    Prediction of risk scores for colorectal cancer patients from the concentration of proteins involved in mitochondrial apoptotic pathway.
    PLoS One. 2019;14:e0217527.
    PubMed     Text format     Abstract available


  64. RAO S, Peri S, Hoffmann J, Cai KQ, et al
    RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance.
    PLoS One. 2019;14:e0222392.
    PubMed     Text format     Abstract available


  65. LICHTBLAU D, Stoean C
    Cancer diagnosis through a tandem of classifiers for digitized histopathological slides.
    PLoS One. 2019;14:e0209274.
    PubMed     Text format     Abstract available


  66. CHIU HC, Hsieh HM, Wan CL, Tsai HL, et al
    Cost-effectiveness of mini-laparotomy in patients with colorectal cancers: A propensity scoring matching approach.
    PLoS One. 2019;14:e0209970.
    PubMed     Text format     Abstract available


  67. PACHECO LS, Anderson CAM, Lacey JV Jr, Giovannucci EL, et al
    Sugar-sweetened beverages and colorectal cancer risk in the California Teachers Study.
    PLoS One. 2019;14:e0223638.
    PubMed     Text format     Abstract available


  68. LI F, Zhang C, Fu L
    PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway.
    PLoS One. 2019;14:e0218839.
    PubMed     Text format     Abstract available


  69. STRACCI F, Gili A, Naldini G, Gianfredi V, et al
    Geospatial analysis of the influence of family doctor on colorectal cancer screening adherence.
    PLoS One. 2019;14:e0222396.
    PubMed     Text format     Abstract available


  70. SOLIMAN C, Eastwood S, Truong VK, Ramsland PA, et al
    The membrane effects of melittin on gastric and colorectal cancer.
    PLoS One. 2019;14:e0224028.
    PubMed     Text format     Abstract available


  71. SINNER HF, Johnson J, Rychahou PG, Watt DS, et al
    Novel chemotherapeutic agent, FND-4b, activates AMPK and inhibits colorectal cancer cell proliferation.
    PLoS One. 2019;14:e0224253.
    PubMed     Text format     Abstract available


  72. KOJIMA K, Nakamura T, Ooizumi Y, Igarashi K, et al
    Clinical significance of cancer specific methylation of the CDO1 gene in small bowel cancer.
    PLoS One. 2019;14:e0211108.
    PubMed     Text format     Abstract available


  73. SHIIZAKI K, Kido K, Mizuta Y
    Insight into the relationship between aryl-hydrocarbon receptor and beta-catenin in human colon cancer cells.
    PLoS One. 2019;14:e0224613.
    PubMed     Text format     Abstract available


  74. HASAKOVA K, Reis R, Vician M, Zeman M, et al
    Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression.
    PLoS One. 2019;14:e0224396.
    PubMed     Text format     Abstract available


  75. WANG S, Shen HW, Chai H, Liang Y, et al
    Complex harmonic regularization with differential evolution in a memetic framework for biomarker selection.
    PLoS One. 2019;14:e0210786.
    PubMed     Text format     Abstract available


  76. FENG Q, Yu H, Sun S, Ma Z, et al
    The value of diffusion kurtosis imaging in assessing mismatch repair gene expression of rectal carcinoma: Preliminary findings.
    PLoS One. 2019;14:e0211461.
    PubMed     Text format     Abstract available


  77. MEDHIN LB, Achila OO, Abrham AT, Efrem B, et al
    Incidence of colorectal cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
    PLoS One. 2019;14:e0224045.
    PubMed     Text format     Abstract available


  78. USHIGOME H, Fukunaga Y, Nagasaki T, Akiyoshi T, et al
    Difficulty of predicting lymph node metastasis on CT in patients with rectal neuroendocrine tumors.
    PLoS One. 2019;14:e0211675.
    PubMed     Text format     Abstract available


  79. SAITO K, Koido S, Odamaki T, Kajihara M, et al
    Metagenomic analyses of the gut microbiota associated with colorectal adenoma.
    PLoS One. 2019;14:e0212406.
    PubMed     Text format     Abstract available


  80. KO CW, Doria-Rose VP, Barrett MJ, Kamineni A, et al
    Screening colonoscopy and flexible sigmoidoscopy for reduction of colorectal cancer incidence: A case-control study.
    PLoS One. 2019;14:e0226027.
    PubMed     Text format     Abstract available


  81. EXARCHAKOU A, Donaldson LJ, Girardi F, Coleman MP, et al
    Colorectal cancer incidence among young adults in England: Trends by anatomical sub-site and deprivation.
    PLoS One. 2019;14:e0225547.
    PubMed     Text format     Abstract available


  82. HUANG Y, Li S, Yue H, Wang M, et al
    Impact of nominal photon energies on normal tissue sparing in knowledge-based radiotherapy treatment planning for rectal cancer patients.
    PLoS One. 2019;14:e0213271.
    PubMed     Text format     Abstract available


  83. HIRANO D, Urabe Y, Tanaka S, Nakamura K, et al
    Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.
    PLoS One. 2019;14:e0211477.
    PubMed     Text format     Abstract available


  84. HE S, Carman CV, Lee JH, Lan B, et al
    The tumor suppressor p53 can promote collective cellular migration.
    PLoS One. 2019;14:e0202065.
    PubMed     Text format     Abstract available


  85. HSU JC, Lin JY, Lin PC, Lee YC, et al
    Comprehensive value assessment of drugs using a multi-criteria decision analysis: An example of targeted therapies for metastatic colorectal cancer treatment.
    PLoS One. 2019;14:e0225938.
    PubMed     Text format     Abstract available


  86. OHLEN J, Sawatzky R, Pettersson M, Sarenmalm EK, et al
    Preparedness for colorectal cancer surgery and recovery through a person-centred information and communication intervention - A quasi-experimental longitudinal design.
    PLoS One. 2019;14:e0225816.
    PubMed     Text format     Abstract available


  87. ALEGRIA-LERTXUNDI I, Aguirre C, Bujanda L, Fernandez FJ, et al
    Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population.
    PLoS One. 2019;14:e0225779.
    PubMed     Text format     Abstract available



  88. Epigenetic silencing of peroxisome proliferator-activated receptor gamma is a biomarker for colorectal cancer progression and adverse patients' outcome.
    PLoS One. 2019;14:e0227376.
    PubMed     Text format    


  89. AWIDI M, Ababneh N, Shomaf M, Al Fararjeh F, et al
    KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan.
    PLoS One. 2019;14:e0226473.
    PubMed     Text format     Abstract available


  90. RENTOFT M, Svensson D, Sjodin A, Olason PI, et al
    A geographically matched control population efficiently limits the number of candidate disease-causing variants in an unbiased whole-genome analysis.
    PLoS One. 2019;14:e0213350.
    PubMed     Text format     Abstract available


  91. CHA YJ, Park EJ, Baik SH, Lee KY, et al
    Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
    PLoS One. 2019;14:e0214415.
    PubMed     Text format     Abstract available


  92. FRANCZAK C, Dubouis L, Gilson P, Husson M, et al
    Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma.
    PLoS One. 2019;14:e0212801.
    PubMed     Text format     Abstract available


  93. MENDIVIL J, Appierto M, Aceituno S, Comas M, et al
    Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review.
    PLoS One. 2019;14:e0227251.
    PubMed     Text format     Abstract available


  94. LEE HJ, Park SJ, Cheon JH, Kim TI, et al
    The relationship between diverticulosis and colorectal neoplasia: A meta-analysis.
    PLoS One. 2019;14:e0216380.
    PubMed     Text format     Abstract available


  95. HASHEMIAN M, Murphy G, Etemadi A, Liao LM, et al
    Potato consumption and the risk of overall and cause specific mortality in the NIH-AARP study.
    PLoS One. 2019;14:e0216348.
    PubMed     Text format     Abstract available


  96. GASSER E, Braunwarth E, Riedmann M, Cardini B, et al
    Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
    PLoS One. 2019;14:e0217411.
    PubMed     Text format     Abstract available


  97. SAITO Y, Hinoi T, Adachi T, Miguchi M, et al
    Synbiotics suppress colitis-induced tumorigenesis in a colon-specific cancer mouse model.
    PLoS One. 2019;14:e0216393.
    PubMed     Text format     Abstract available


  98. ALAM MA, Shahjaman M, Rahman MF, Hossain F, et al
    Gene shaving using a sensitivity analysis of kernel based machine learning approach, with applications to cancer data.
    PLoS One. 2019;14:e0217027.
    PubMed     Text format     Abstract available


  99. JUROWICH C, Lichthardt S, Kastner C, Haubitz I, et al
    Laparoscopic versus open right hemicolectomy in colon carcinoma: A propensity score analysis of the DGAV StuDoQ|ColonCancer registry.
    PLoS One. 2019;14:e0218829.
    PubMed     Text format     Abstract available


  100. RABIN-COURT A, Rodrigues MR, Zhang XM, Perry RJ, et al
    Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation.
    PLoS One. 2019;14:e0218126.
    PubMed     Text format     Abstract available


  101. YARCHOAN M, Mohan AA, Dennison L, Vithayathil T, et al
    MEK inhibition suppresses B regulatory cells and augments anti-tumor immunity.
    PLoS One. 2019;14:e0224600.
    PubMed     Text format     Abstract available


  102. HIDALGO-TENORIO C, Gil-Anguita C, Lopez Ruz MA, Omar M, et al
    ART is key to clearing oncogenic HPV genotypes (HR-HPV) in anal mucosa of HIV-positive MSM.
    PLoS One. 2019;14:e0224183.
    PubMed     Text format     Abstract available


  103. KATSIDZIRA L, Vorster A, Gangaidzo IT, Makunike-Mutasa R, et al
    Investigation on the hereditary basis of colorectal cancers in an African population with frequent early onset cases.
    PLoS One. 2019;14:e0224023.
    PubMed     Text format     Abstract available


  104. GRUENDNER J, Schwachhofer T, Sippl P, Wolf N, et al
    KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.
    PLoS One. 2019;14:e0223010.
    PubMed     Text format     Abstract available


  105. MUNRO MJ, Wickremesekera SK, Peng L, Marsh RW, et al
    Cancer stem cell subpopulations in primary colon adenocarcinoma.
    PLoS One. 2019;14:e0221963.
    PubMed     Text format     Abstract available


  106. CHEN R, Sugiyama A, Seno H, Sugimoto M, et al
    Identification of modules and functional analysis in CRC subtypes by integrated bioinformatics analysis.
    PLoS One. 2019;14:e0221772.
    PubMed     Text format     Abstract available


  107. SNOWSILL TM, Ryan NAJ, Crosbie EJ, Frayling IM, et al
    Cost-effectiveness analysis of reflex testing for Lynch syndrome in women with endometrial cancer in the UK setting.
    PLoS One. 2019;14:e0221419.
    PubMed     Text format     Abstract available


  108. FLORESCU A, Branisteanu D, Bilha S, Scripcariu D, et al
    Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences.
    PLoS One. 2019;14:e0212471.
    PubMed     Text format     Abstract available


  109. WANG Q, Fu J, Chen X, Cai C, et al
    What factors are associated with the poor prognosis of anal adenocarcinoma compared with low-lying rectal adenocarcinoma based on a population analysis: A propensity score matching study.
    PLoS One. 2019;14:e0219937.
    PubMed     Text format     Abstract available


  110. JANSSEN TL, Steyerberg EW, Langenberg JCM, de Lepper CCHAVH, et al
    Multimodal prehabilitation to reduce the incidence of delirium and other adverse events in elderly patients undergoing elective major abdominal surgery: An uncontrolled before-and-after study.
    PLoS One. 2019;14:e0218152.
    PubMed     Text format     Abstract available


  111. MOFERS A, Perego P, Selvaraju K, Gatti L, et al
    Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
    PLoS One. 2019;14:e0223807.
    PubMed     Text format     Abstract available


  112. BERMUDEZ LUNA R, de Torres Olombrada MV
    mARC preoperative rectal cancer treatments vs. 3D conformal radiotherapy. A dose distribution comparative study.
    PLoS One. 2019;14:e0221262.
    PubMed     Text format     Abstract available


    January 2018
  113. LIN CY, Lin TH, Chen CC, Chen MC, et al
    Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.
    PLoS One. 2018;13:e0190497.
    PubMed     Text format     Abstract available


  114. FAN F, Wang R, Boulbes DR, Zhang H, et al
    Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway.
    PLoS One. 2018;13:e0190070.
    PubMed     Text format     Abstract available


  115. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Text format     Abstract available


  116. ZHANG Y, Liu H, Li L, Ai M, et al
    Correction: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2018;13:e0191587.
    PubMed     Text format     Abstract available


  117. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Text format     Abstract available


  118. MUGHINI-GRAS L, Schaapveld M, Kramers J, Mooij S, et al
    Increased colon cancer risk after severe Salmonella infection.
    PLoS One. 2018;13:e0189721.
    PubMed     Text format     Abstract available


  119. MAKONDI PT, Lee CH, Huang CY, Chu CM, et al
    Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    PLoS One. 2018;13:e0189582.
    PubMed     Text format     Abstract available


  120. GOMES SE, Pereira DM, Roma-Rodrigues C, Fernandes AR, et al
    Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells.
    PLoS One. 2018;13:e0191607.
    PubMed     Text format     Abstract available


  121. SILVA DAS, Tremblay MS, Souza MFM, Mooney M, et al
    Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study.
    PLoS One. 2018;13:e0190943.
    PubMed     Text format     Abstract available


  122. LI F, Li Q, Wu X
    Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
    PLoS One. 2018;13:e0192494.
    PubMed     Text format     Abstract available


  123. CATALANO C, da Silva Filho MI, Frank C, Jiraskova K, et al
    Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.
    PLoS One. 2018;13:e0192385.
    PubMed     Text format     Abstract available


  124. HE Y, Penney ME, Negandhi AA, Parfrey PS, et al
    XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer.
    PLoS One. 2018;13:e0192316.
    PubMed     Text format     Abstract available


  125. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Text format     Abstract available


  126. SHETH H, Northwood E, Ulrich CM, Scherer D, et al
    Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
    PLoS One. 2018;13:e0192223.
    PubMed     Text format     Abstract available


  127. FRANZ J, Grunebaum J, Schafer M, Mulac D, et al
    Rhombic organization of microvilli domains found in a cell model of the human intestine.
    PLoS One. 2018;13:e0189970.
    PubMed     Text format     Abstract available


  128. MARCUELLO M, Mayol X, Felipe-Fumero E, Costa J, et al
    Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.
    PLoS One. 2018;13:e0192958.
    PubMed     Text format     Abstract available


  129. CHOI JW, Kim DK, Kim JK, Lee EJ, et al
    A retrospective analysis on the relationship between intraoperative hypothermia and postoperative ileus after laparoscopic colorectal surgery.
    PLoS One. 2018;13:e0190711.
    PubMed     Text format     Abstract available


  130. GALLERY M, Zhang J, Bradley DP, Brauer P, et al
    A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    PLoS One. 2018;13:e0191046.
    PubMed     Text format     Abstract available


  131. JUNG YS, Park CH, Kim NH, Park JH, et al
    Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    PLoS One. 2018;13:e0191125.
    PubMed     Text format     Abstract available


  132. WANG H, Du K, Qu J, Chandarana H, et al
    Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.
    PLoS One. 2018;13:e0190883.
    PubMed     Text format     Abstract available


  133. SCHIRRIPA M, Zhang W, Yang D, Cao S, et al
    NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
    PLoS One. 2018;13:e0193640.
    PubMed     Text format     Abstract available


  134. MARLICZ W, Poniewierska-Baran A, Rzeszotek S, Bartoszewski R, et al
    A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
    PLoS One. 2018;13:e0189337.
    PubMed     Text format     Abstract available


  135. ARELAKI S, Arampatzioglou A, Kambas K, Sivridis E, et al
    Mast cells co-expressing CD68 and inorganic polyphosphate are linked with colorectal cancer.
    PLoS One. 2018;13:e0193089.
    PubMed     Text format     Abstract available


  136. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Text format     Abstract available


  137. FENG S, Zhou Q, Yang B, Li Q, et al
    The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.
    PLoS One. 2018;13:e0192208.
    PubMed     Text format     Abstract available


  138. JIAO X, Liu W, Mahdessian H, Bryant P, et al
    Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
    PLoS One. 2018;13:e0193547.
    PubMed     Text format     Abstract available


  139. ORTIZ-ORTIZ KJ, Tortolero-Luna G, Rios-Motta R, Veintidos-Feliu A, et al
    Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    PLoS One. 2018;13:e0194415.
    PubMed     Text format     Abstract available


  140. HOLM M, Saraswat M, Joenvaara S, Ristimaki A, et al
    Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    PLoS One. 2018;13:e0195354.
    PubMed     Text format     Abstract available


  141. LU J, Hu X, Meng Y, Zhao H, et al
    The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer.
    PLoS One. 2018;13:e0194804.
    PubMed     Text format     Abstract available


  142. SULZYC-BIELICKA V, Kolodziejczyk L, Jaczewska S, Bielicki D, et al
    Colorectal cancer and Cryptosporidium spp. infection.
    PLoS One. 2018;13:e0195834.
    PubMed     Text format     Abstract available


  143. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Text format     Abstract available


  144. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    PubMed     Text format     Abstract available


  145. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    PubMed     Text format     Abstract available


  146. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    PubMed     Text format     Abstract available


  147. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0197008.
    PubMed     Text format     Abstract available


  148. KOJIMA K, Nakamura T, Ohbu M, Katoh H, et al
    Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    PLoS One. 2018;13:e0194785.
    PubMed     Text format     Abstract available


  149. MOLPARIA B, Oliveira G, Wagner JL, Spencer EG, et al
    A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
    PLoS One. 2018;13:e0196826.
    PubMed     Text format     Abstract available


  150. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2018;13:e0197765.
    PubMed     Text format     Abstract available


  151. KUAN TC, Lin PC, Yang SH, Lin CC, et al
    Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.
    PLoS One. 2018;13:e0197681.
    PubMed     Text format     Abstract available


  152. CHAT-UTHAI N, Vejvisithsakul P, Udommethaporn S, Meesiri P, et al
    Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
    PLoS One. 2018;13:e0198795.
    PubMed     Text format     Abstract available


  153. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    PubMed     Text format     Abstract available


  154. AWAN R, Al-Maadeed S, Al-Saady R
    Using spectral imaging for the analysis of abnormalities for colorectal cancer: When is it helpful?
    PLoS One. 2018;13:e0197431.
    PubMed     Text format     Abstract available


  155. ALJARBOU F, Almousa N, Bazzi M, Aldaihan S, et al
    The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients.
    PLoS One. 2018;13:e0197154.
    PubMed     Text format     Abstract available


  156. YU Y, Cheng D, Parfrey P, Liu G, et al
    Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
    PLoS One. 2018;13:e0198873.
    PubMed     Text format     Abstract available


  157. MESSARITAKIS I, Stogiannitsi M, Koulouridi A, Sfakianaki M, et al
    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
    PLoS One. 2018;13:e0197327.
    PubMed     Text format     Abstract available


  158. HUHN S, da Silva Filho MI, Sanmuganantham T, Pichulik T, et al
    Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.
    PLoS One. 2018;13:e0199350.
    PubMed     Text format     Abstract available


  159. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Text format     Abstract available


  160. SAMRAJ AN, Bertrand KA, Luben R, Khedri Z, et al
    Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    PLoS One. 2018;13:e0197464.
    PubMed     Text format     Abstract available


  161. QUINTANA JM, Anton-Ladislao A, Gonzalez N, Lazaro S, et al
    Predictors of one and two years' mortality in patients with colon cancer: A prospective cohort study.
    PLoS One. 2018;13:e0199894.
    PubMed     Text format     Abstract available


  162. GAVARUZZI T, Sarlo M, Giandomenico F, Rumiati R, et al
    Assessing emotions conveyed and elicited by patient narratives and their impact on intention to participate in colorectal cancer screening: A psychophysiological investigation.
    PLoS One. 2018;13:e0199882.
    PubMed     Text format     Abstract available


  163. PARK J, Kim JH, Park Y, Park SJ, et al
    Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.
    PLoS One. 2018;13:e0193753.
    PubMed     Text format     Abstract available


  164. DAVIDSEN J, Larsen S, Coskun M, Gogenur I, et al
    The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
    PLoS One. 2018;13:e0200215.
    PubMed     Text format     Abstract available


  165. NODA M, Okayama H, Kofunato Y, Chida S, et al
    Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
    PLoS One. 2018;13:e0200315.
    PubMed     Text format     Abstract available


  166. INOUE M, Uchida Y, Edagawa M, Hirata M, et al
    The stress response gene ATF3 is a direct target of the Wnt/beta-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells.
    PLoS One. 2018;13:e0194160.
    PubMed     Text format     Abstract available


  167. FOSTER CC, Lee AY, Furtado LV, Hart J, et al
    Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
    PLoS One. 2018;13:e0194234.
    PubMed     Text format     Abstract available


  168. PERRIER L, Rascle P, Morelle M, Toulmonde M, et al
    The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.
    PLoS One. 2018;13:e0193330.
    PubMed     Text format     Abstract available


  169. WALI RK, Bianchi L, Kupfer S, De La Cruz M, et al
    Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
    PLoS One. 2018;13:e0193544.
    PubMed     Text format     Abstract available


  170. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Text format     Abstract available


  171. MOJTABANEZHAD SHARIATPANAHI A, Yassi M, Nouraie M, Sahebkar A, et al
    The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    PLoS One. 2018;13:e0200735.
    PubMed     Text format     Abstract available


  172. GUERCIO BJ, Zhang S, Niedzwiecki D, Li Y, et al
    Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
    PLoS One. 2018;13:e0199244.
    PubMed     Text format     Abstract available


  173. ATREYA CE, Kubo A, Borno HT, Rosenthal B, et al
    Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.
    PLoS One. 2018;13:e0199423.
    PubMed     Text format     Abstract available


  174. TAI YH, Chang WK, Wu HL, Chan MY, et al
    The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0200893.
    PubMed     Text format     Abstract available


  175. CHANG JY, Moon CM, Lee HJ, Yang HJ, et al
    Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: A KASID multicenter study.
    PLoS One. 2018;13:e0195709.
    PubMed     Text format     Abstract available


  176. SAITA C, Yamaguchi T, Horiguchi SI, Yamada R, et al
    Tumor development in Japanese patients with Lynch syndrome.
    PLoS One. 2018;13:e0195572.
    PubMed     Text format     Abstract available


  177. EBELING M, Modig K, Ahlbom A, Rau R, et al
    The effects of increasing longevity and changing incidence on lifetime risk differentials: A decomposition approach.
    PLoS One. 2018;13:e0195307.
    PubMed     Text format     Abstract available


  178. TAKEDA Y, Akiyoshi T, Matsueda K, Fukuoka H, et al
    Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
    PLoS One. 2018;13:e0195406.
    PubMed     Text format     Abstract available


  179. GHOSH R, Roy S, Franco S
    PARP1 depletion induces RIG-I-dependent signaling in human cancer cells.
    PLoS One. 2018;13:e0194611.
    PubMed     Text format     Abstract available


  180. JANSEN RJ, Alexander BH, Hayes RB, Miller AB, et al
    A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
    PLoS One. 2018;13:e0194608.
    PubMed     Text format     Abstract available


  181. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Text format     Abstract available


  182. BOGACHEV MI, Volkov VY, Markelov OA, Trizna EY, et al
    Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images.
    PLoS One. 2018;13:e0193267.
    PubMed     Text format     Abstract available


  183. KIM MJ, Hur BY, Lee ES, Park B, et al
    Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    PLoS One. 2018;13:e0195815.
    PubMed     Text format     Abstract available


  184. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Text format     Abstract available


  185. SCHREMBS P, Martin B, Anthuber M, Schenkirsch G, et al
    The prognostic significance of lymph node size in node-positive colon cancer.
    PLoS One. 2018;13:e0201072.
    PubMed     Text format     Abstract available


  186. TAI YH, Chang WK, Wu HL, Chan MY, et al
    Correction: The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0202192.
    PubMed     Text format     Abstract available


  187. NEERINCX M, Poel D, Sie DLS, van Grieken NCT, et al
    Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.
    PLoS One. 2018;13:e0201809.
    PubMed     Text format     Abstract available


  188. STANILOVA S, Stanilov N, Julianov A, Manolova I, et al
    Transforming growth factor-beta1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    PLoS One. 2018;13:e0201775.
    PubMed     Text format     Abstract available


  189. PRENTICE LM, Miller RR, Knaggs J, Mazloomian A, et al
    Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
    PLoS One. 2018;13:e0196434.
    PubMed     Text format     Abstract available


  190. PAL R, Wei N, Song N, Wu S, et al
    Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.
    PLoS One. 2018;13:e0200836.
    PubMed     Text format     Abstract available


  191. DEN BAKKER CM, Anema JR, Zaman AGNM, de Vet HCW, et al
    Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review.
    PLoS One. 2018;13:e0200720.
    PubMed     Text format     Abstract available


  192. LYNN H, Sun X, Ayshiev D, Siegler JH, et al
    Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.
    PLoS One. 2018;13:e0200916.
    PubMed     Text format     Abstract available


  193. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively.
    PLoS One. 2018;13:e0202856.
    PubMed     Text format     Abstract available


  194. MURCIA O, Juarez M, Rodriguez-Soler M, Hernandez-Illan E, et al
    Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
    PLoS One. 2018;13:e0203051.
    PubMed     Text format     Abstract available


  195. DHATCHANA MOORTHY N, Muthu Ramalingam B, Iqbal S, Mohanakrishnan AK, et al
    Novel isothiacalothrixin B analogues exhibit cytotoxic activity on human colon cancer cells in vitro by inducing irreversible DNA damage.
    PLoS One. 2018;13:e0202903.
    PubMed     Text format     Abstract available


  196. DECKER KM, Nugent Z, Lambert P, Biswanger N, et al
    Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    PLoS One. 2018;13:e0203321.
    PubMed     Text format     Abstract available


  197. SEO MK, Cairns J
    Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
    PLoS One. 2018;13:e0204496.
    PubMed     Text format     Abstract available


  198. MARTIN-MORALES L, Rofes P, Diaz-Rubio E, Llovet P, et al
    Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    PLoS One. 2018;13:e0203885.
    PubMed     Text format     Abstract available


  199. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Text format     Abstract available


  200. KANG S, Kim BR, Kang MH, Kim DY, et al
    Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
    PLoS One. 2018;13:e0205449.
    PubMed     Text format     Abstract available


  201. SU TC, Chen CY, Tsai WC, Hsu HT, et al
    Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    PLoS One. 2018;13:e0204866.
    PubMed     Text format     Abstract available


  202. BROWN JC, Rhim AD, Manning SL, Brennan L, et al
    Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer.
    PLoS One. 2018;13:e0204875.
    PubMed     Text format     Abstract available



  203. Retraction: Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2018;13:e0206398.
    PubMed     Text format    


  204. CHUN KA, Kocarnik JM, Hardikar SS, Robinson JR, et al
    Leptin gene variants and colorectal cancer risk: Sex-specific associations.
    PLoS One. 2018;13:e0206519.
    PubMed     Text format     Abstract available


  205. SHAH MS, DeSantis T, Yamal JM, Weir T, et al
    Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    PLoS One. 2018;13:e0207002.
    PubMed     Text format     Abstract available


  206. MENG C, Yin X, Liu J, Tang K, et al
    TIMP-1 is a novel serum biomarker for the diagnosis of colorectal cancer: A meta-analysis.
    PLoS One. 2018;13:e0207039.
    PubMed     Text format     Abstract available


  207. HERSTAD KMV, Moen AEF, Gaby JC, Moe L, et al
    Characterization of the fecal and mucosa-associated microbiota in dogs with colorectal epithelial tumors.
    PLoS One. 2018;13:e0198342.
    PubMed     Text format     Abstract available


  208. JODOIN R, Perreault JP
    G-quadruplexes formation in the 5'UTRs of mRNAs associated with colorectal cancer pathways.
    PLoS One. 2018;13:e0208363.
    PubMed     Text format     Abstract available


  209. GUO G, Chen X, He W, Wang H, et al
    Establishment of inflammation biomarkers-based nomograms to predict prognosis of advanced colorectal cancer patients based on real world data.
    PLoS One. 2018;13:e0208547.
    PubMed     Text format     Abstract available


  210. SHOJAEE S, Hajizadeh N, Najafimehr H, Busani L, et al
    Bayesian adjustment for trend of colorectal cancer incidence in misclassified registering across Iranian provinces.
    PLoS One. 2018;13:e0199273.
    PubMed     Text format     Abstract available


  211. AGYEMANG-YEBOAH F, Yorke J, Obirikorang C, Nsenbah Batu E, et al
    Colorectal cancer survival rates in Ghana: A retrospective hospital-based study.
    PLoS One. 2018;13:e0209307.
    PubMed     Text format     Abstract available


  212. DAMIN F, Galbiati S, Soriani N, Burgio V, et al
    Analysis of KRAS, NRAS and BRAF mutational profile by combination of in-tube hybridization and universal tag-microarray in tumor tissue and plasma of colorectal cancer patients.
    PLoS One. 2018;13:e0207876.
    PubMed     Text format     Abstract available


  213. BAAS J, Krens L, Bohringer S, Mol L, et al
    Genome wide association study to identify predictors for severe skin toxicity in colorectal cancer patients treated with cetuximab.
    PLoS One. 2018;13:e0208080.
    PubMed     Text format     Abstract available


  214. HAGMAN H, Bendahl PO, Lidfeldt J, Belting M, et al
    Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer.
    PLoS One. 2018;13:e0209838.
    PubMed     Text format     Abstract available


  215. LAW E, Levesque JV, Lambert S, Girgis A, et al
    The "sphere of care": A qualitative study of colorectal cancer patient and caregiver experiences of support within the cancer treatment setting.
    PLoS One. 2018;13:e0209436.
    PubMed     Text format     Abstract available


  216. WANG X, Zheng B, Lu X, Bai R, et al
    Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data.
    PLoS One. 2018;13:e0200142.
    PubMed     Text format     Abstract available


  217. BAUMER N, Rehkamper J, Appel N, Terheyden L, et al
    Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth.
    PLoS One. 2018;13:e0200163.
    PubMed     Text format     Abstract available


  218. TATEBAYASHI D, Himori K, Yamada R, Ashida Y, et al
    High-intensity eccentric training ameliorates muscle wasting in colon 26 tumor-bearing mice.
    PLoS One. 2018;13:e0199050.
    PubMed     Text format     Abstract available


  219. SOMMER CA, Capilla A, Molina-Estevez FJ, Gianotti-Sommer A, et al
    Modeling APC mutagenesis and familial adenomatous polyposis using human iPS cells.
    PLoS One. 2018;13:e0200657.
    PubMed     Text format     Abstract available


  220. AUGUSTUS GJ, Roe DJ, Jacobs ET, Lance P, et al
    Is increased colorectal screening effective in preventing distant disease?
    PLoS One. 2018;13:e0200462.
    PubMed     Text format     Abstract available


  221. PIASECKI P, Narloch J, Brzozowski K, Ziecina P, et al
    The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.
    PLoS One. 2018;13:e0200488.
    PubMed     Text format     Abstract available


  222. RODRIGUEZ-ALONSO L, Rodriguez-Moranta F, Arajol C, Gilabert P, et al
    Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
    PLoS One. 2018;13:e0203359.
    PubMed     Text format     Abstract available


  223. REDFORD L, Alhilal G, Needham S, O'Brien O, et al
    A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours.
    PLoS One. 2018;13:e0203052.
    PubMed     Text format     Abstract available


  224. ESTEVA M, Ruiz-Diaz M, Sanchez MA, Pertega S, et al
    Emergency presentation of colorectal patients in Spain.
    PLoS One. 2018;13:e0203556.
    PubMed     Text format     Abstract available


  225. MILONE M, Manigrasso M, Burati M, Velotti N, et al
    Surgical resection for rectal cancer. Is laparoscopic surgery as successful as open approach? A systematic review with meta-analysis.
    PLoS One. 2018;13:e0204887.
    PubMed     Text format     Abstract available


  226. MAJUMDER S, Shah R, Elias J, Mistry Y, et al
    A neoepitope derived from a novel human germline APC gene mutation in familial adenomatous polyposis shows selective immunogenicity.
    PLoS One. 2018;13:e0203845.
    PubMed     Text format     Abstract available


  227. INABA S, Hinohara A, Tachibana M, Tsujikawa K, et al
    Muscle regeneration is disrupted by cancer cachexia without loss of muscle stem cell potential.
    PLoS One. 2018;13:e0205467.
    PubMed     Text format     Abstract available


  228. PEACOCK SD, Massey TE, Vanner SJ, King WD, et al
    Telomere length in the colon is related to colorectal adenoma prevalence.
    PLoS One. 2018;13:e0205697.
    PubMed     Text format     Abstract available


  229. CAMPOS NA, da Cunha MSB, Arruda SF
    Tucum-do-cerrado (Bactris setosa Mart.) modulates oxidative stress, inflammation, and apoptosis-related proteins in rats treated with azoxymethane.
    PLoS One. 2018;13:e0206670.
    PubMed     Text format     Abstract available


  230. KIRAGA L, Cheda L, Taciak B, Rozanska K, et al
    Changes in hypoxia level of CT26 tumors during various stages of development and comparing different methods of hypoxia determination.
    PLoS One. 2018;13:e0206706.
    PubMed     Text format     Abstract available


  231. SHRIVASTAV M, Gounaris E, Khan MW, Ko J, et al
    Validation of near infrared fluorescence (NIRF) probes in vivo with dual laser NIRF endoscope.
    PLoS One. 2018;13:e0206568.
    PubMed     Text format     Abstract available


  232. CAMPAYO M, Navarro A, Benitez JC, Santasusagna S, et al
    miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer.
    PLoS One. 2018;13:e0206542.
    PubMed     Text format     Abstract available


  233. CHEN YY, Fang WH, Wang CC, Kao TW, et al
    Detrimental association between betel nut chewing and colorectal polyps in adult populations.
    PLoS One. 2018;13:e0206383.
    PubMed     Text format     Abstract available


  234. KANG YJ, Smith M, Canfell K
    Anal cancer in high-income countries: Increasing burden of disease.
    PLoS One. 2018;13:e0205105.
    PubMed     Text format     Abstract available


  235. GRACE D, Gaspar M, Paquette R, Rosenes R, et al
    HIV-positive gay men's knowledge and perceptions of Human Papillomavirus (HPV) and HPV vaccination: A qualitative study.
    PLoS One. 2018;13:e0207953.
    PubMed     Text format     Abstract available


  236. HUANG MH, Blackwood J, Godoshian M, Pfalzer L, et al
    Factors associated with self-reported falls, balance or walking difficulty in older survivors of breast, colorectal, lung, or prostate cancer: Results from Surveillance, Epidemiology, and End Results-Medicare Health Outcomes Survey linkage.
    PLoS One. 2018;13:e0208573.
    PubMed     Text format     Abstract available


    January 2017
  237. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    PubMed     Text format     Abstract available


  238. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    PubMed     Text format     Abstract available


  239. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    PubMed     Text format     Abstract available


  240. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available


  241. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    PubMed     Text format     Abstract available


  242. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    PubMed     Text format     Abstract available


  243. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    PubMed     Text format     Abstract available


  244. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    PubMed     Text format     Abstract available


  245. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Text format     Abstract available


  246. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    PubMed     Text format     Abstract available


  247. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    PubMed     Text format     Abstract available


  248. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Text format     Abstract available


  249. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    PubMed     Text format     Abstract available


  250. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    PubMed     Text format     Abstract available


  251. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    PubMed     Text format     Abstract available


  252. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    PubMed     Text format     Abstract available


  253. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    PubMed     Text format     Abstract available


  254. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Text format     Abstract available


  255. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  256. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    PubMed     Text format     Abstract available


  257. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    PubMed     Text format     Abstract available


  258. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    PubMed     Text format     Abstract available


  259. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Text format     Abstract available


  260. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    PubMed     Text format     Abstract available


  261. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    PubMed     Text format     Abstract available


  262. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Text format     Abstract available


  263. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    PubMed     Text format     Abstract available


  264. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    PubMed     Text format     Abstract available


  265. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    PubMed     Text format     Abstract available


  266. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    PubMed     Text format     Abstract available


  267. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    PubMed     Text format     Abstract available


  268. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    PubMed     Text format     Abstract available


  269. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    PubMed     Text format     Abstract available


  270. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Text format     Abstract available


  271. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available


  272. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    PubMed     Text format     Abstract available


  273. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    PubMed     Text format     Abstract available


  274. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Text format     Abstract available


  275. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    PubMed     Text format     Abstract available


  276. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    PubMed     Text format     Abstract available


  277. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    PubMed     Text format     Abstract available


  278. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    PubMed     Text format     Abstract available


  279. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Text format     Abstract available


  280. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    PubMed     Text format     Abstract available


  281. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    PubMed     Text format     Abstract available


  282. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    PubMed     Text format     Abstract available


  283. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    PubMed     Text format     Abstract available


  284. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    PubMed     Text format     Abstract available


  285. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    PubMed     Text format     Abstract available


  286. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    PubMed     Text format     Abstract available


  287. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    PubMed     Text format     Abstract available


  288. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    PubMed     Text format     Abstract available


  289. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    PubMed     Text format     Abstract available


  290. YU Z, Chen Z, Wu J, Li Z, et al
    Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0188139.
    PubMed     Text format     Abstract available


  291. PARK H, Cho S, Woo H, Park SK, et al
    Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.
    PLoS One. 2017;12:e0188465.
    PubMed     Text format     Abstract available


  292. BIEN SA, Auer PL, Harrison TA, Qu C, et al
    Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.
    PLoS One. 2017;12:e0186518.
    PubMed     Text format     Abstract available


  293. HUO T, Canepa R, Sura A, Modave F, et al
    Colorectal cancer stages transcriptome analysis.
    PLoS One. 2017;12:e0188697.
    PubMed     Text format     Abstract available


  294. ROVELLI C, Poli A, Galli L, Cernuschi M, et al
    Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.
    PLoS One. 2017;12:e0186367.
    PubMed     Text format     Abstract available


  295. ZHANG Z, Zheng F, Yu Z, Hao J, et al
    XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    PLoS One. 2017;12:e0186900.
    PubMed     Text format     Abstract available


  296. HWANG IC, Chang J, Park SM
    Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    PLoS One. 2017;12:e0189114.
    PubMed     Text format     Abstract available


  297. BERRY RS, Xiong MJ, Greenbaum A, Mortaji P, et al
    High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.
    PLoS One. 2017;12:e0188799.
    PubMed     Text format     Abstract available


  298. LORCA V, Rueda D, Martin-Morales L, Poves C, et al
    Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
    PLoS One. 2017;12:e0187312.
    PubMed     Text format     Abstract available


  299. HOEDJES M, de Kruif A, Mols F, Bours M, et al
    An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study.
    PLoS One. 2017;12:e0189178.
    PubMed     Text format     Abstract available


  300. SERRANO-VILLAR S, Hernandez-Novoa B, de Benito A, Del Romero J, et al
    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
    PLoS One. 2017;12:e0188851.
    PubMed     Text format     Abstract available


  301. GRAF JF, Zavodszky MI
    Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.
    PLoS One. 2017;12:e0188878.
    PubMed     Text format     Abstract available


  302. MA L, Wang L, Shan Y, Nafees M, et al
    Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
    PLoS One. 2017;12:e0188665.
    PubMed     Text format     Abstract available


  303. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    PubMed     Text format     Abstract available


  304. VIRGONE-CARLOTTA A, Lemasson M, Mertani HC, Diaz JJ, et al
    In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
    PLoS One. 2017;12:e0188100.
    PubMed     Text format     Abstract available


  305. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    PubMed     Text format     Abstract available


  306. KOENIG A, Krug S, Mueller D, Barth PJ, et al
    Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
    PLoS One. 2017;12:e0188876.
    PubMed     Text format     Abstract available


  307. OSMAN M, Benamrouz S, Guyot K, Baydoun M, et al
    High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients.
    PLoS One. 2017;12:e0189422.
    PubMed     Text format     Abstract available


  308. GONG J, Bai T, Zhang L, Qian W, et al
    Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro.
    PLoS One. 2017;12:e0189257.
    PubMed     Text format     Abstract available


  309. O'NEIL BH, Wallmark JM, Lorente D, Elez E, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
    PLoS One. 2017;12:e0189848.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: